CAS: 695-56-7; 1,4-Dioxaspiro[4.4]Non-6-Ene

该化合物是一个双环有机化合物,其特点是独特的螺旋结构,由连接到环己烷框架的二氧环组成,该化合物具有二氧烷混合物内的两个氧原子,有助于其稳定性和反应性;该化合物通常没有色素,可粉色黄色液体,有独特的味;环己烷部分存在双环己烷部分,因此有可能在各种化学反应中产生回活动,包括聚合和添加反应. 1,4-Dioxaspiro[4]none-6-en,由于其结构特性,对有机合成和材料科学很感兴趣,这可能影响聚合物和其他材料的物理和化学行为.此外,其螺旋结构可产生独特的天体和电子特性,使其成为研究医药化学和开发新化学实体的宝贵化合物.应参考安全数据,以便处理和储存所有化学物质.

结构式图片

相似化合物

1004-58-6 177-10-6 51656-90-7

欧盟法规

ECHA物质C&L通报REACH预注册

上下游产品

CAS号120-92-3 环戊酮 | CAS号930-30-3 2-环戊烯酮 | CAS号107-21-1 乙二醇 | CAS号697-22-3 6-chloro-1,4-di... | CAS号694-28-0 2-氯环戊酮 | CAS号3859-41-4 1,3-环戊二酮 | CAS号25404-15-3 1,4-dioxaspiro[... | CAS号114627-44-0 6-methylidenebi... | CAS号75988-55-5 7-bromo-1,4-dio... | CAS号75988-63-5 1,4-Dioxaspiro[...

合成工艺路线路线简述

    📜环戊酮置于溴体系中,用 乙二醇 作为反应溶剂,化学反应生成 2-环戊烯-1-酮缩乙醛
    参考文献:N-Amino Bicyclic Compounds
    标题:N-Amino Bicyclic Compounds
    摘要:N-氨基六氢环戊咪唑-2(1H)-酮衍生物,用于治疗或预防由增加眼压引起的血栓栓塞性疾病和眼部疾病.

    海关参考信息

    专利信息


    专利号:US-7612106-B2
    优先权日:2004-12-23
    标题 :Fused pyrazole derivatives and methods of treatment of metabolic-related disorders thereof
    发明人:BOATMAN P DOUGLAS; SCHRADER THOMAS O; SEMPLE GRAEME; SKINNER PHILIP J; JUNG JAE-KYU
    权利人:ARENA PHARM INC
    摘要:The present invention relates to certain fused pyrazole derivatives of Formula (Ia), and pharmaceutically acceptable salts thereof, which exhibit useful pharmacological properties, for example, as agonists for the RUP25 receptor. n nAlso provided by the present invention are pharmaceutical compositions containing compounds of the invention, and methods of using the compounds and compositions of the invention in the treatment of metabolic-related disorders, including dyslipidemia, atherosclerosis, coronary heart disease, insulin resistance, type 2 diabetes, Syndrome-X and the like. In addition, the present invention also provides for the use of the compounds of the invention in combination with other active agents such as those belonging to the class of α-glucosidase inhibitors, aldose reductase inhibitors, biguanides, HMG-CoA reductase inhibitors, squalene synthesis inhibitors, fibrates, LDL catabolism enhancers, angiotensin converting enzyme (ACE) inhibitors, insulin secretion enhancers, DP receptor antagonists, and the like.

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    合成参考文献


    摘要:Yus, M.; Foubelo, F., Science of Synthesis Knowledge Updates, (2012) 1, 85.
    摘要:Andrus, M. B., Science of Synthesis: Stereoselective Synthesis, (2011) 3, 476.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知